Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
iSpecimen Inc. (ISPC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/04/2023 |
8-K
| Quarterly results|
Docs:
|
"iSpecimen Inc. Condensed Balance Sheets March 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 3,762,654 $ 15,308,710 Available-for-sale securities 7,259,482 — Accounts receivable – unbilled 1,584,440 2,327,789 Accounts receivable, net of allowance for doubtful accounts of $383,789 and $230,999 at March 31, 2023 and December 31, 2022, respectively 3,005,832 1,597,915 Prepaid expenses and other current assets 312,900 300,434 Tax credit receivable 34,669 140,873 Total current assets 15,959,977 19,675,721 Property and equipment, net 195,293 225,852 Internally developed software, net 5,610,007 4,503,787 Operating lease right-of-use asset 146,193 184,692 Security deposits 27,601 27,601 Total assets $ 21,939,071 $ 24,617,653 LIABILITIES AND STOCKHOLDERS’ EQUITY Curre...",
"This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such statements are only predictions and our actual results ma..." |
|
| 03/14/2023 |
8-K
| Quarterly results|
Docs:
|
"iSpecimen Inc. Condensed Balance Sheets December 31, December 31, 2022 2021 Unaudited ASSETS Current assets: Cash $ 15,308,710 $ 27,738,979 Accounts receivable - unbilled 2,327,789 1,739,020 Accounts receivable, net of allowance for doubtful accounts of $230,999 and $269,170 at December 31, 2022 and 2021, respectively 1,597,915 3,002,442 Prepaid expenses and other current assets 300,434 327,035 Tax credit receivable, current portion 140,873 140,873 Total current assets 19,675,721 32,948,349 Property and equipment, net 225,852 32,781 Internally developed software, net 4,503,787 2,710,867 Operating lease right-of-use asset 184,692 — Security deposits 27,601 27,601 Total assets $ 24,617,653 $ 35,719,598 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,459,063 $ 8...",
"SUPPLY HEALTHCARE PROVIDERS DEMAND LIFE SCIENCE RESEARCHERS" |
|
| 11/08/2022 |
8-K
| Quarterly results|
Docs:
|
"iSpecimen Inc. Condensed Balance Sheets September 30, December 31, 2022 2021 ASSETS Current assets: Cash $ 20,657,719 $ 27,738,979 Accounts receivable - unbilled 1,311,222 1,739,020 Accounts receivable, net of allowance for doubtful accounts of $215,845 and $269,170 at September 30, 2022 and December 31, 2021, respectively 1,784,805 3,002,442 Prepaid expenses and other current assets 341,555 327,035 Tax credit receivable, net of current portion 140,873 140,873 Total current assets 24,236,174 32,948,349 Property and equipment, net 19,194 32,781 Internally developed software, net 3,434,344 2,710,867 Right-of-use asset 222,626 — Security deposits 27,601 27,601 Total assets $ 27,939,939 $ 35,719,598 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 967,735 $ 832,678 ...",
"CONNECT. INNOVATE. TRANSFORMING PROCUREMENT BIOSPECIMEN" |
|
| 08/04/2022 |
8-K
| Quarterly results|
Docs:
|
"iSpecimen Inc. Condensed Balance Sheets June 30, 2022 December 31, 2021 ASSETS Current assets: Cash $ 23,691,175 $ 27,738,979 Accounts receivable - unbilled 1,264,278 1,739,020 Accounts receivable, net of allowance for doubtful accounts of $289,207 and $269,170 at June 30, 2022 and December 31, 2021, respectively 1,660,076 3,002,442 Prepaid expenses and other current assets 374,867 327,035 Tax credit receivable, current portion 140,873 140,873 Total current assets 27,131,269 32,948,349 Property and equipment, net 23,648 32,781 Internally developed software, net 2,954,936 2,710,867 Operating lease right-of-use asset 260,003 — Security deposits 27,601 27,601 Total assets $ 30,397,457 $ 35,719,598 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 433,026 $ 832,678 A...",
"SUPPLY HEALTHCARE PROVIDERS DEMAND LIFE SCIENCE RESEARCHERS" |
|
| 05/10/2022 |
8-K
| Quarterly results|
Docs:
|
"iSpecimen Inc. BALANCE SHEETS March 31, 2022 December 31, 2021 Assets Cash $ 26,099,178 $ 27,738,979 Accounts receivable - unbilled 1,258,515 1,739,020 Accounts receivable, net of allowance 2,356,688 3,002,442 Prepaid expenses and other current assets 295,750 327,035 Tax credit receivable, net of current portion 140,873 140,873 Property and equipment, net 28,069 32,781 Internally developed software, net 2,783,810 2,710,867 Operating lease right-of-use asset 296,832 - Security deposits 27,601 27,601 Total Assets $ 33,287,316 $ 35,719,598 Liabilities Accounts payable $ 281,494 $ 832,678 Accrued expenses 1,039,974 1,009,803 Accrued interest 8,167 8,167 Operating lease current obligation 150,007 - Deferred revenue 567,321 654,746 Operating lease long-term obligation 147,375 - Term loan, net of...",
"CONNECT. INNOVATE. May 2022 Investor Presentation TRANSFORMING BIOSPECIMEN PROCUREMENT An online marketplace for human biospecimens" |
|
| 02/17/2022 |
8-K
| Quarterly results |
| 08/10/2021 |
8-K
| Quarterly results |
|
|